171 related articles for article (PubMed ID: 18226478)
1. Quantitative determination of thallium binding to ferric hexacyanoferrate: Prussian blue.
Yang Y; Faustino PJ; Progar JJ; Brownell CR; Sadrieh N; May JC; Leutzinger E; Place DA; Duffy EP; Yu LX; Khan MA; Lyon RC
Int J Pharm; 2008 Apr; 353(1-2):187-94. PubMed ID: 18226478
[TBL] [Abstract][Full Text] [Related]
2. Quantitative determination of cesium binding to ferric hexacyanoferrate: Prussian blue.
Faustino PJ; Yang Y; Progar JJ; Brownell CR; Sadrieh N; May JC; Leutzinger E; Place DA; Duffy EP; Houn F; Loewke SA; Mecozzi VJ; Ellison CD; Khan MA; Hussain AS; Lyon RC
J Pharm Biomed Anal; 2008 May; 47(1):114-25. PubMed ID: 18242038
[TBL] [Abstract][Full Text] [Related]
3. Long-term stability study of Prussian blue - a quality assessment of water content and thallium binding.
Mohammad A; Faustino PJ; Khan MA; Yang Y
Int J Pharm; 2014 Dec; 477(1-2):122-7. PubMed ID: 25311178
[TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation of the thallium binding of soluble and insoluble Prussian blue hexacyanoferrate analogs: A scientific comparison based on their critical quality attributes.
Faustino PJ; Brown A; Lowry B; Yang Y; Wang Y; Khan MA; Dunbar KR; Mohammad A
Int J Pharm; 2019 Oct; 569():118600. PubMed ID: 31401298
[TBL] [Abstract][Full Text] [Related]
5. Validation of an in vitro method for the determination of cyanide release from ferric-hexacyanoferrate: Prussian blue.
Yang Y; Brownell CR; Sadrieh N; May JC; Del Grosso AV; Lyon RC; Faustino PJ
J Pharm Biomed Anal; 2007 Mar; 43(4):1358-63. PubMed ID: 17174056
[TBL] [Abstract][Full Text] [Related]
6. A long-term stability study of Prussian blue: A quality assessment of water content and cesium binding.
Mohammad A; Yang Y; Khan MA; Faustino PJ
J Pharm Biomed Anal; 2015 Jan; 103():85-90. PubMed ID: 25462125
[TBL] [Abstract][Full Text] [Related]
7. Long-term stability study of Prussian blue-A quality assessment of water content and cyanide release.
Mohammad A; Yang Y; Khan MA; Faustino PJ
Clin Toxicol (Phila); 2015 Feb; 53(2):102-7. PubMed ID: 25608705
[TBL] [Abstract][Full Text] [Related]
8. Quantitative measurement of cyanide released from Prussian Blue.
Yang Y; Brownell C; Sadrieh N; May J; Del A
Clin Toxicol (Phila); 2007; 45(7):776-81. PubMed ID: 17924254
[TBL] [Abstract][Full Text] [Related]
9. Soluble or insoluble prussian blue for radiocesium and thallium poisoning?
Thompson DF; Callen ED
Ann Pharmacother; 2004 Sep; 38(9):1509-14. PubMed ID: 15252192
[TBL] [Abstract][Full Text] [Related]
10. Oral formulation of Prussian blue with improved efficacy for prophylactic use against thallium.
Sandal N; Kumar V; Sharma P; Yadav M
Drug Dev Ind Pharm; 2023 Feb; 49(2):149-158. PubMed ID: 36912805
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of prussian blue against thallium poisoning: effect of particle size.
Rios C; Kravsov J; Altagracia M; Lopez-Naranjo F; Monroy A
Proc West Pharmacol Soc; 1991; 34():61-3. PubMed ID: 1788342
[No Abstract] [Full Text] [Related]
12. Relationship between physicochemical properties of prussian blue and its efficacy as antidote against thallium poisoning.
Kravzov J; Rios C; Altagracia M; Monroy-Noyola A; López F
J Appl Toxicol; 1993; 13(3):213-6. PubMed ID: 8326092
[TBL] [Abstract][Full Text] [Related]
13. Are 2,3-dimercapto-1-propanesulfonic acid or prussian blue beneficial in acute thallotoxicosis in rats?
Mulkey JP; Oehme FW
Vet Hum Toxicol; 2000 Dec; 42(6):325-9. PubMed ID: 11111936
[TBL] [Abstract][Full Text] [Related]
14. Rate of iron transfer through the horse spleen ferritin shell determined by the rate of formation of Prussian Blue and Fe-desferrioxamine within the ferritin cavity.
Zhang B; Watt RK; Gálvez N; Domínguez-Vera JM; Watt GD
Biophys Chem; 2006 Mar; 120(2):96-105. PubMed ID: 16314026
[TBL] [Abstract][Full Text] [Related]
15. A Prussian blue-based reactive electrode (reactrode) for the determination of thallium ions.
Kahlert H; Komorsky-Lovrić S; Hermes M; Scholz F
Anal Bioanal Chem; 1996 Sep; 356(3-4):204-8. PubMed ID: 15048354
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of thallium adsorption by activated charcoal, prussian blue, and sodium polystyrene sulfonate.
Hoffman RS; Stringer JA; Feinberg RS; Goldfrank LR
J Toxicol Clin Toxicol; 1999; 37(7):833-7. PubMed ID: 10630266
[TBL] [Abstract][Full Text] [Related]
17. Additive effect of DL-penicillamine plus Prussian blue for the antidotal treatment of thallotoxicosis in rats.
Montes S; Pérez-Barrón G; Rubio-Osornio M; Ríos C; Diaz-Ruíz A; Altagracia-Martínez M; Monroy-Noyola A
Environ Toxicol Pharmacol; 2011 Nov; 32(3):349-55. PubMed ID: 22004953
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of nanodispersed molecular aggregates of Prussian blue in aerosol OT reverse micelle.
Pramanik S; Das D; Das K; Bhattacharya SCh
J Nanosci Nanotechnol; 2007 Feb; 7(2):663-7. PubMed ID: 17450811
[TBL] [Abstract][Full Text] [Related]
19. pH-dependent Release Matrix Oral Formulation of Prussian Blue to Improve its Efficacy as an Internal Decorporation Agent.
Agrawal V; Sandal N; Singh AK; Pathak DP
Curr Drug Deliv; 2021; 18(8):1162-1173. PubMed ID: 33504305
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo removal efficacy of insoluble Prussian blue in combination with calcium polystyrene sulfonate for thallium.
Jain S; Kumar V; Koul A; Singh AK; Sandal N
Biometals; 2023 Oct; 36(5):1125-1140. PubMed ID: 37222858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
